You are about to action:

Object being modified by the action

Do you want to proceed?

Share Video Link

https://www.bitchute.com/video/TG3zSwoh0B2m/

Click to copy, then share by pasting into your messages, comments, social media posts and websites.

Embed Video HTML

Click to copy, then add into your webpages so users can view and engage with this video from your site.

Share to Social Media

Share to social media by clicking on the quick share links.

Report Content

Reason

Please select the most appropriate reason from the list provided.

Note: For a more detailed description of each reason, see our Community Guidelines.

Additional Comments

Please add any additonal comments that will help with the assessment of your request.

Note: Copyright claims must contain all the items specified within the Copyright Policy.

Email Submissions

We also accept reports via email. Please see the Guidelines Enforcement Process for instructions on how to make a request via email.

Thank you for submitting your report

We will investigate and take the appropriate action.

Add to Playlist

Segment - "The Stew Peters Show" - 10/11/2021

Next video playing soon

Click to cancel

Autoplay has been paused

Click to watch next video

First published at 10:23 UTC on October 12th, 2021.

#covid-19
#vaccines
#pfizer

iamasheep

subscribers

Your platform for uncensored ideas. BitChute Premium.

BitChute Advertisement

Continuing interview series of Karen Kingston, a pharmaceutical industry data analyst and researcher with extensive experience in the fore mentioned industry including have completed contracts with Pfizer, among others. I personally am disturbed by the information discussed. This is not a joke. She is reading from published patents, whether or not they were approved does not matter. Filing patent applications is not a free service, it is a high cost process requiring legal council, research firms, and comes with extraordinarily steep fees at this level of business. The people filing for these patents would not expend the money required to complete the process unless the intellectual property or the invention or innovation of the said technology was not at least somewhat viable to possibly produce profit in the future. I am at a loss for words.

LESS